Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
CNY 8.89
(-0.89%)
CNY 8.89
(-0.89%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.35 Billion CNY | 5.76% |
| 2022 | 1.28 Billion CNY | 11.27% |
| 2021 | 1.15 Billion CNY | 76.53% |
| 2020 | 652.88 Million CNY | 5.36% |
| 2019 | 619.66 Million CNY | 108.76% |
| 2018 | 296.83 Million CNY | 70.79% |
| 2017 | 173.79 Million CNY | 41.22% |
| 2016 | 123.06 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.39 Billion CNY | 2.93% |
| 2024 Q2 | 1.39 Billion CNY | -0.14% |
| 2023 Q4 | 1.35 Billion CNY | -8.06% |
| 2023 Q1 | 1.2 Billion CNY | -6.2% |
| 2023 Q2 | 1.18 Billion CNY | -1.63% |
| 2023 Q3 | 1.47 Billion CNY | 24.68% |
| 2023 FY | 1.35 Billion CNY | 5.76% |
| 2022 Q1 | 1.33 Billion CNY | 16.17% |
| 2022 FY | 1.28 Billion CNY | 11.27% |
| 2022 Q4 | 1.28 Billion CNY | 1.75% |
| 2022 Q3 | 1.26 Billion CNY | -1.05% |
| 2022 Q2 | 1.27 Billion CNY | -4.86% |
| 2021 FY | 1.15 Billion CNY | 76.53% |
| 2021 Q4 | 1.15 Billion CNY | 4.11% |
| 2021 Q3 | 1.1 Billion CNY | 1.73% |
| 2021 Q2 | 1.08 Billion CNY | 8.95% |
| 2021 Q1 | 998.84 Million CNY | 52.99% |
| 2020 FY | 652.88 Million CNY | 5.36% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 652.88 Million CNY | -0.66% |
| 2020 Q2 | 652.76 Million CNY | 0.0% |
| 2020 Q3 | 657.19 Million CNY | 0.68% |
| 2019 FY | 619.66 Million CNY | 108.76% |
| 2019 Q4 | 619.66 Million CNY | 0.0% |
| 2019 Q1 | 524.08 Million CNY | 0.0% |
| 2018 FY | 296.83 Million CNY | 70.79% |
| 2017 FY | 173.79 Million CNY | 41.22% |
| 2016 FY | 123.06 Million CNY | 0.0% |